Hansen Gwenn Insider Trading Activity
Hansen Gwenn has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
NRIX is the most-traded position with 5 trades. The largest single transaction was a sale of NRIX for $80K on Jan 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Hansen Gwenn. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.1% | 60% | 5 |
| 90 days | — | -8.9% | 50% | 4 |
| 120 days | — | -19.2% | 0% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersNRIX · Nurix Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Hansen Gwenn bought and sold NRIX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | NRIX | Sell | 3,214 | $16.65 | $53K | Chief Scientific Officer |
| Jan 30, 2026 | NRIX | Sell | 4,797 | $16.58 | $80K | Chief Scientific Officer |
| Jan 30, 2026 | NRIX | Sell | 98 | $17.37 | $2K | Chief Scientific Officer |
| Oct 30, 2025 | NRIX | Sell | 4,087 | $12.80 | $52K | Chief Scientific Officer |
| Jul 30, 2025 | NRIX | Sell | 4,308 | $12.01 | $52K | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 5 | $239K |
Other insiders at Nurix Therapeutics, Inc.
2 other tracked filers at NRIX.